Nephrogen
Curative gene therapies for kidney diseases
New York, United States · Founded 2022 · $325K raised
- Headquarters
- New York, New York
- Employees
- 1–10
- Founded
- 2022
- Website
- nephrogenbiotech.com
- Total Funding
- $325K
- Last Round
- $325K GrantSep 2023
- Rounds
- 1
About
Nephrogen is a biotech company developing curative gene therapies for kidney and pancreatic diseases. Kidney disease affects 1 in 7 Americans (~50 million people), has no cure, and accounts for nearly 10% of the Medicare budget.
Summary
Nephrogen is a Biotech company based in New York, United States, founded in 2022. It has raised $325K in total across 1 round, most recently a $325K Grant round in Sep 2023.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2023
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/nephrogen"><img src="https://indexed.vc/api/badge/company/nephrogen" alt="Nephrogen on Indexed.vc" width="260" height="76" /></a>